関連する実験動画
Updated: Sep 10, 2025

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
348
2型先天性汎用性脂質変形症のブラジル人患者におけるメトロレプチンの長期臨床経験
Isabella Sued Leão1, Joana Rodrigues Dantas1, Sarah Galvão2
1Medical Clinic Department, Nutrology and Diabetes Unit, Universidade Federal do Rio de Janeiro, Rio de Janeiro, 21941-913, Brazil.
JCEM case reports
|August 27, 2025
まとめ
メトロレプチンは,先天性汎用性脂質消化症2型患者の代謝機能障害を8年間効果的に管理しました. これらの患者の持続的な代謝制御には,継続的なメトレプチンの治療が不可欠です.
科学分野:
- 内分泌学
- 遺伝学
- 代謝障害
背景:
- 生まれながらの一般化型脂質変性2型 (BSCL2遺伝子変異) は,重度のインスリン抵抗性を示します.
- メトリレプチンは,脂質消化症に対するレプチン置換療法です.
- BSCL2関連リポジストロフィーにおけるメトレプチンの長期的なデータは限られている.
さらに関連する動画
関連する概念動画
Insulin: Dosing Regimen and Adverse Effects
257
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
257
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K

